DaVita Inc.
DVA
Hisse Senetlerindeki Sıralama
#1794
DaVita Inc. specializes in delivering essential kidney dialysis treatments and... DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
Hisse Fiyatı
$187.07
Piyasa Değeri
$11.94B
Değişim (1 gün)
0.14%
Değişim (1 yıl)
48.61%
Ülke
US
Ticaret DaVita Inc. (DVA)
Kategori
Healthcare
DaVita Inc. (DVA) için kazanç
Jun 2026 itibarıyla kazanç TTM: $1.47B
DaVita Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı $1.47B'dir. 2024 yılında şirket $1.53B kazanç elde etti, bu 2023 yılındaki $1.18B kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
DaVita Inc. için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $1.47B | 8.98% |
| 2025 | $1.35B | -11.99% |
| 2024 | $1.53B | 30.01% |
| 2023 | $1.18B | 21.82% |
| 2022 | $966.28M | -36.37% |
| 2021 | $1.52B | 15.19% |
| 2020 | $1.32B | 10.27% |
| 2019 | $1.20B | 14.02% |
| 2018 | $1.05B | -25.10% |
| 2017 | $1.40B | -5.98% |
| 2016 | $1.49B | 105.89% |
| 2015 | $723.14M | -44.78% |
| 2014 | $1.31B | 16.42% |
| 2013 | $1.12B | 12.35% |
| 2012 | $1.00B | 12.17% |
| 2011 | $892.67M | 19.91% |
| 2010 | $744.46M | -1.82% |
| 2009 | $758.22M | 24.41% |
| 2008 | $609.46M | -2.88% |
| 2007 | $627.52M | 31.90% |
| 2006 | $475.76M | 43.69% |
| 2005 | $331.10M | -8.51% |
| 2004 | $361.88M | 25.54% |
| 2003 | $288.27M | -8.83% |
| 2002 | $316.19M | 31.23% |
| 2001 | $240.94M | 436.19% |
| 2000 | $44.94M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $9.87B | 572.50% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 163.32% |
US
|
|
| $687.82M | -53.14% |
SA
|
|
| $1.25B | -15.06% |
BR
|
